|
1841 |
Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?
Enthalten in Osteoporosis international Bd. 28, 13.7.2017, Nr. 8, date:8.2017: 2429-2430
|
|
|
|
1842 |
Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: response to Driessen et al
Enthalten in Osteoporosis international Bd. 28, 13.7.2017, Nr. 8, date:8.2017: 2431
|
|
|
|
1843 |
Fragilitätsfrakturen: Osteoporose-Diagnostik nicht auf die lange Bank schieben
Enthalten in Orthopädie & Rheuma Bd. 20, 11.12.2017, Nr. 6, date:12.2017: 42
|
|
|
|
1844 |
Framework for Advancing the Reporting of Patient Engagement in Rheumatology Research Projects
Enthalten in Current rheumatology reports Bd. 19, 19.6.2017, Nr. 7, date:7.2017: 1-10
|
|
|
|
1845 |
FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry
Enthalten in Osteoporosis international Bd. 28, 7.6.2017, Nr. 9, date:9.2017: 2557-2564
|
|
|
|
1846 |
Frequency of inflammatory-like MR imaging findings in asymptomatic fingers of healthy volunteers
Enthalten in Skeletal radiology Bd. 47, 6.11.2017, Nr. 2, date:2.2018: 279-287
|
|
|
|
1847 |
Friction massage versus kinesiotaping for short-term management of latent trigger points in the upper trapezius: a randomized controlled trial
Enthalten in Chiropractic & manual therapies Bd. 25, 12.9.2017, Nr. 1, date:12.2017: 1-6
|
|
|
|
1848 |
Frühe rheumatoide Arthritis: Optimale MTX-Dosis erzielt bessere Ergebnisse
Enthalten in Orthopädie & Rheuma Bd. 20, 11.12.2017, Nr. 6, date:12.2017: 12
|
|
|
|
1849 |
Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis
Enthalten in Nature Communications Bd. 9, 23.2.2018, Nr. 1, date:12.2018: 1-11
|
|
|
|
1850 |
Fundraising bringt Kliniken zusätzliche Mittel ein
Enthalten in Orthopädie & Rheuma Bd. 20, 14.6.2017, Nr. 3, date:6.2017: 49
|
|
Administration
